Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. AVAH
stocks logo

AVAH

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Intellectia AI SwingMax
Intellectia AI SwingMax

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
622.47M
+19.74%
0.127
+153.62%
616.25M
+10.2%
0.134
+33.83%
634.58M
+7.64%
0.148
-17.53%
Estimates Revision
The market is revising Upward the revenue expectations for Aveanna Healthcare Holdings Inc. (AVAH) for FY2025, with the revenue forecasts being adjusted by 0.78% over the past three months. During the same period, the stock price has changed by 6.87%.
Revenue Estimates for FY2025
Revise Upward
up Image
+0.78%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
up Image
+25.25%
In Past 3 Month
Stock Price
Go Up
up Image
+6.87%
In Past 3 Month
Wall Street analysts forecast AVAH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AVAH is 10.44 USD with a low forecast of 9.00 USD and a high forecast of 12.50 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
8 Analyst Rating
Wall Street analysts forecast AVAH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AVAH is 10.44 USD with a low forecast of 9.00 USD and a high forecast of 12.50 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
4 Buy
4 Hold
0 Sell
Moderate Buy
Current: 9.020
sliders
Low
9.00
Averages
10.44
High
12.50
Current: 9.020
sliders
Low
9.00
Averages
10.44
High
12.50
BMO Capital
Outperform
initiated
$11
2025-11-12
Reason
BMO Capital
Price Target
$11
2025-11-12
initiated
Outperform
Reason
BMO Capital initiated coverage of Aveanna with an Outperform rating and $11 price target. Shares are up about 130% since early August on strong Q2 and Q3 results fueled by state reimbursement increases, preferred payer expansion, and disciplined cost control, which also lowered leverage, the analyst tells investors in a research note. While future Medicaid rate hikes may be limited, ongoing payer conversions, cost discipline, and potential M&A underpin expectations for 10+ long-term EBITDA growth, the firm says.
UBS
AJ Rice
Neutral
maintain
$9
2025-11-07
Reason
UBS
AJ Rice
Price Target
$9
2025-11-07
maintain
Neutral
Reason
UBS analyst AJ Rice raised the firm's price target on Aveanna to $9.50 from $9 and keeps a Neutral rating on the shares.
Jefferies
Buy
maintain
$11
2025-10-28
Reason
Jefferies
Price Target
$11
2025-10-28
maintain
Buy
Reason
Jefferies raised the firm's price target on Aveanna to $12.50 from $11 and keeps a Buy rating on the shares after the company announced a secondary offering of 10M shares along with preliminary Q3 results last week. The preliminary results reflect management's success in securing favorable reimbursement, driving volume and EBITDA growth, the analyst tells investors.
RBC Capital
Ben Hendrix
Sector Perform
maintain
$8 -> $10
2025-10-23
Reason
RBC Capital
Ben Hendrix
Price Target
$8 -> $10
2025-10-23
maintain
Sector Perform
Reason
RBC Capital analyst Ben Hendrix raised the firm's price target on Aveanna to $10 from $8 and keeps a Sector Perform rating on the shares. The company reported strong preliminary Q3 results that came in well ahead of expectations, the analyst tells investors in a research note. The firm also believes J.H. Whitney's recently priced sale of 10M shares should begin to ease the stock's private equity and share liquidity overhang.
Truist
Hold
to
Hold
upgrade
2025-10-14
Reason
Truist
Price Target
2025-10-14
upgrade
Hold
to
Hold
Reason
Truist raised the firm's price target on Aveanna to $9.50 from $6.50 and keeps a Hold rating on the shares as part of a broader research note previewing Q3 results in Healthcare Service. The firm is "broadly bullish" on the industry as it expects ongoing strength in core demand drivers and continues to like the long-term positioning of covered names within their sector verticals, coupled with improved visibility around the regulatory environment, the analyst tells investors in a research note. Strong free cash flows and attractive financial flexibility across the bulk of the sector underpins the ongoing growth investment, Truist notes, adding that it sees a "brisk opportunity" to deploy capital to further augment core growth and drive M&A.
JPMorgan
Underweight -> Neutral
upgrade
$6 -> $10
2025-09-18
Reason
JPMorgan
Price Target
$6 -> $10
2025-09-18
upgrade
Underweight -> Neutral
Reason
JPMorgan upgraded Aveanna to Neutral from Underweight with a price target of $10, up from $6, after assuming coverage of the name. The firm views current outpatient environment to be most favorable for companies with lower reimbursement exposure to federal funding. Aveanna's value proposition represents a "unique way" to gain exposure to the shift to home health, but if faces a challenging rate environment and broader reimbursement risk, the analyst tells investors in a research note.
See All Ratings

Valuation Metrics

The current forward P/E ratio for Aveanna Healthcare Holdings Inc (AVAH.O) is 16.40, compared to its 5-year average forward P/E of 39.87. For a more detailed relative valuation and DCF analysis to assess Aveanna Healthcare Holdings Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
39.87
Current PE
16.40
Overvalued PE
146.35
Undervalued PE
-66.61

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
12.46
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
14.17
Undervalued EV/EBITDA
10.74

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.42
Current PS
0.00
Overvalued PS
0.70
Undervalued PS
0.13
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders areSelling! The selling amount has increased 2356.91% over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders areSelling! The selling amount has increased 2356.91% over the last month.
Sold
Bought
AI Stock Picker
AI Stock Picker

AVAH News & Events

Events Timeline

(ET)
2025-11-06
06:51:36
Aveanna increases FY25 revenue forecast to exceed $2.375B, up from over $2.3B
select
2025-11-06
06:49:52
Aveanna announces Q3 adjusted EPS of 15 cents, surpassing consensus estimate of 14 cents.
select
2025-10-22 (ET)
2025-10-22
10:00:03
Aveanna Experiences a 11.9% Decline
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
3.0
12-09NASDAQ.COM
Are Options Indicating a Surge in Aveanna Healthcare Stock?

  • Aveanna Healthcare Stock Analysis: Investors should monitor Aveanna Healthcare Holdings Inc. (AVAH) due to high implied volatility in its options market, indicating expectations of significant price movement, potentially linked to upcoming events.

  • Analyst Sentiment: Aveanna Healthcare holds a Zacks Rank #2 (Buy) in the Medical - Outpatient and Home Healthcare sector, with recent earnings estimates rising from 8 cents to 13 cents per share, reflecting positive analyst sentiment.

  • Options Trading Strategy: The high implied volatility may present trading opportunities, particularly for seasoned options traders who often sell premium to capitalize on stock price stability at expiration.

  • Quantum Computing Insights: Quantum computing is rapidly advancing, with major tech companies integrating it into their operations, and investment strategist Kevin Cook identifies key stocks that may lead in this emerging field.

[object Object]
Preview
1.0
12-05Globenewswire
Aveanna Healthcare to Attend BofA Home Care Conference on December 9, 2025
  • Conference Participation: Aveanna Healthcare's management team will attend the BofA Securities Home Care Conference on December 9, 2025, showcasing its expertise in healthcare services, which is expected to attract investor interest and enhance the company's visibility.
  • Investor Engagement: The management will present at 12:30pm EST and host 1x1 investor meetings, aiming to strengthen relationships with potential investors and drive future financing opportunities.
  • Online Replay: The presentation will be webcasted via the company's website, allowing investors who cannot attend live to access the information, thereby expanding the reach of communication and enhancing transparency.
  • Service Range: Aveanna provides a diverse range of healthcare services across 38 states, including pediatric and adult care, designed to offer high-quality, lower-cost alternatives to prolonged hospitalization, thereby enhancing its competitive position in the market.
[object Object]
Preview
4.0
12-04NASDAQ.COM
Daily Upgrade Report for Validea's Joel Greenblatt Strategy - December 4, 2025

  • Aveanna Healthcare Holdings Inc. Rating: The stock rating for Aveanna Healthcare Holdings Inc. (AVAH) improved from 80% to 90% based on its strong fundamentals and valuation, indicating strong interest from the Earnings Yield Investor model by Joel Greenblatt.

  • CorMedix Inc. Rating: CorMedix Inc. (CRMD) also saw its rating rise dramatically from 0% to 90%, reflecting significant improvement in its underlying fundamentals and stock valuation, suggesting strong interest according to the same investment strategy.

  • Company Descriptions: Aveanna Healthcare provides diversified home care services, including private duty nursing and hospice care, while CorMedix focuses on developing therapeutic products to prevent and treat serious health conditions, particularly related to catheter-related infections.

  • About Joel Greenblatt and Validea: Joel Greenblatt is known for his "Magic Formula" investment strategy, which has historically outperformed the market, and Validea is an investment research service that applies strategies from various successful investors, including Greenblatt.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Aveanna Healthcare Holdings Inc (AVAH) stock price today?

The current price of AVAH is 9.02 USD — it has decreased -0.88 % in the last trading day.

arrow icon

What is Aveanna Healthcare Holdings Inc (AVAH)'s business?

Aveanna Healthcare Holdings Inc. is a provider of diversified home care platforms. Its segments include Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). PDS segment includes private duty nursing (PDN) services, as well as pediatric therapy services. HHH segment includes home health services, as well as hospice and specialty program services. Its home health services involve the provision of in-home services to its patients by its clinicians, which include nurses, therapists, social workers and home health aides. Its hospice services involve a supportive philosophy and concept of care for those nearing the end of life. Medical Solutions segment offers a line of enteral nutrition supplies and other products to adults and children, delivered on a periodic or as-needed basis. It also provides case management services to assist families and patients by coordinating the provision of services between insurers and other healthcare providers.

arrow icon

What is the price predicton of AVAH Stock?

Wall Street analysts forecast AVAH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AVAH is 10.44 USD with a low forecast of 9.00 USD and a high forecast of 12.50 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Aveanna Healthcare Holdings Inc (AVAH)'s revenue for the last quarter?

Aveanna Healthcare Holdings Inc revenue for the last quarter amounts to 621.94M USD, increased 22.18 % YoY.

arrow icon

What is Aveanna Healthcare Holdings Inc (AVAH)'s earnings per share (EPS) for the last quarter?

Aveanna Healthcare Holdings Inc. EPS for the last quarter amounts to 0.06 USD, decreased -127.27 % YoY.

arrow icon

What changes have occurred in the market's expectations for Aveanna Healthcare Holdings Inc (AVAH)'s fundamentals?

The market is revising Upward the revenue expectations for Aveanna Healthcare Holdings Inc. (AVAH) for FY2025, with the revenue forecasts being adjusted by 0.78% over the past three months. During the same period, the stock price has changed by 6.87%.
arrow icon

How many employees does Aveanna Healthcare Holdings Inc (AVAH). have?

Aveanna Healthcare Holdings Inc (AVAH) has 3500 emplpoyees as of December 13 2025.

arrow icon

What is Aveanna Healthcare Holdings Inc (AVAH) market cap?

Today AVAH has the market capitalization of 1.88B USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free